RABEZOL
Gastro-resistant tablet, 20mg
RxActive license
Active substance (INN)
rabeprazole
Pharmaceutical form
Pharmaceutical formGastro-resistant tablet
Strength20mg
PackagingUkupno 14 gastrorezistentnih tableta u blisteru (1x14) u kartonskoj kutiji
ManufacturerLaboratorios Liconsa, Spain
Therapeutic groupAlimentary tract and metabolism (A02BC04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 16, 2025
Source: CInMED register